The researchers were Associate Professor Dr. Iman Tariq Ali and Prof. Dr. Azza Sajid from the College of Pharmacy, Professor Dr. Hadeel Salman from the College of Medicine Al-Zahraa and Prof. Dr. Saad Shaheen Hammadi from the College of Medicine; They published a paper entitled (Extensive Study on Hematological, Immunological, Inflammatory Markers, and Biochemical Profile to Identify the Risk Factors in COVID-19 Patients) in the International Journal of Inflammation with CiteScore7.700 and within the second quarter of Scopus classification
The study included detection of tissue damage caused by COVID-19 infection by several clinical indicators including immunological, inflammatory, hematological and biochemical markers. The aim of the study was to reveal these clinical criteria through the relationship between factors and their roles in the development of COVID-19, and to explore which factors are more dangerous that lead to exacerbation of the disease in severe cases. factor]
The study found that COVID-19 patients had leukocytosis, with increased neutrophil count and decreased lymphocyte count, with respect to inflammatory parameters, both ESR and hs-CRP showed significant discrepancies between the two groups, while IL-6 was significantly higher. in the severe group compared to the other two groups.
The study concluded that the development of COVID-19 in severe cases through a complex network of factors linked with each other, which leads to a decrease and an increase in some immune and inflammatory indicators, which affects the levels of hematological parameters such as the numbers of lymphocytes, neutrophils and biochemical parameters, and thus affects the inflammatory response through an increase in the level of cytokines. . The results of this study may help in the mechanism of diagnosing infection with the virus and how to avoid exacerbation of the disease when infected with it.
